論文（邦文）
- 精巣上体炎, 精巣炎
今日の治療指針 私はこう治療している
- 杉元幹史; TODAY'S THERAPY2021 1248-1249
- 転移性去勢抵抗性前立腺癌(mCRPC)の治療および骨の健康と骨転移マネジメント APCCC2019を日本の臨床に照らして考察する
- 鈴木啓悦, 木村高弘, 杉元幹史, 横溝晃, 上村博司; 泌尿器外科 (0914-6180)33巻6号 Page595-601(2020.06)
- 転移性ホルモン感受性前立腺癌(mHSPC)の診断と治療 APCCC2019を日本の実臨床に照らして考察する
- 鈴木啓悦, 木村高弘, 杉元幹史, 横溝晃, 上村博司; 泌尿器外科 (0914-6180)33巻7号 Page989-997(2020.07)
- 非転移性去勢抵抗性前立腺癌(M0CRPC/nmCRPC)の診断と治療 APCCC2019を日本の実臨床に照らして考察する
- 鈴木啓悦, 木村高弘, 杉元幹史, 横溝晃, 上村博司; 泌尿器外科 (0914-6180)33巻5号 Page513-520(2020.05)
- 【高齢患者の泌尿器疾患を診る-転ばぬ先の薬と手術】高齢者に対する手術の適応と限界 泌尿器癌を有する高齢者の治療前評価
- 常森寛行, 杉元幹史; 臨床泌尿器科 (0385-2393)74巻6号 Page386-390(2020.05)
- 筋層非浸潤性膀胱癌の治療戦略：2nd TURBTとBCG膀胱内注入療法の役割
- 田岡利宜也, 杉元幹史; 西日本泌尿器科 82(1):45-51
- 泌尿器科的エマージェンシー
- 田岡利宜也; 新臨床腫瘍学 655-656
- 【前立腺癌治療の合併症・副作用マネージメント】監視療法 メンタルケア・複数回生検による合併症(解説/特集)
- 加藤琢磨, 杉元幹史; Prostate Journal (2188-4978)7巻1号 Page12-19(2020.04)
- 監視療法の現状と問題点 (特集 前立腺がんの過剰診断・過剰治療の解決策)
- 土肥洋一郎, 宮内康行, 加藤琢磨, 杉元幹史; 泌尿器科, 11(1):28-36, 2020
- Active surveillanceの現状と展望 (特集 前立腺癌診療update : 最新の診断と治療) - (診断と治療)
- 土肥洋一郎, 杉元幹史; 日本臨床 78(6) 953 - 959 2020年6月
- 監視療法（特集 今だからこそ考える限局性前立腺癌に対する治療）
- 土肥洋一郎, 杉元幹史; 泌尿器外科 33巻11号 Page 1381-1386
論文（英文）
- Stromal-epithelial interactions in prostate cancer: Overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells.
- Fu S, Liu T, Lv C, Fu C, Zeng R, Kakehi Y, Kulkarni P, Getzenberg RH, Zeng Y.; J Cell Biochem. 2020 Nov;121(11):4406-4418.
- Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer.
- Inokuchi J, Kuroiwa K, Nishiyama H, Kojima T, Kakehi Y, Sugimoto M, Takenaka A, Fujimoto K, Yamaguchi R, Habuchi T, Hashine K, Mizusawa J, Eba J, Naito S; Urologic Oncology Study Group of the Japan Clinical Oncology Group (JCOG).; Int J Urol. 2021 Feb;28(2):208-214
- Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401).
- Yokomizo A, Wakabayashi M, Satoh T, Hashine K, Inoue T, Fujimoto K, Egawa S, Habuchi T, Kawashima K, Ishizuka O, Shinohara N, Sugimoto M, Yoshino Y, Nihei K, Fukuda H, Tobisu KI, Kakehi Y, Naito S; JCOG0401 Investigators.; Eur Urol. 2020 Jun;77(6):689-698.
- Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma.
- Nakai Y, Takeuchi A, Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Minami K, Ueda K, Ozawa M, Uemura M, Miyauchi Y, Ohba K, Kashiwagi A, Murakami M, Sazuka T, Yasumoto H, Morizane S, Kawasaki Y, Morooka D, Shimazui T, Yamamoto Y, Nakagomi H, Tomida R, Ito YM, Murai S, Kitamura H, Nishiyama H, Shinohara N; Japanese Urological Oncology Group.; J Geriatr Oncol. 2020 Dec 30:S1879-4068(20)30534-8.
- Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients.
- Shiota M, Terada N, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S, Kamiyama M, Tanaka N, Mitsuzuka K, Kato T, Narita S, Yasumoto H, Teraoka S, Kato M, Osawa T, Nagumo Y, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Inoue T, Mizowaki T, Kamoto T, Kojima T, Kitamura H, Sugimoto M, Nishiyama H, Eto M, Urological Oncology Group Juog J.; Cancer Sci. 2020 Nov 7. doi: 10.1111/cas.14722.
- Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml.
- Ito K, Yokomizo A, Tokunaga S, Arai G, Sugimoto M, Akakura K, Hasumi H, Sakai H, Ouraji A, Oki R, Kashiwagi E, Kobori Y, Hirama H, Kitoh H, Uemura H, Hakariya T, Suzuki K; Members of PROPHET.; J Urol. 2020 Jan;203(1):83-91. doi: 10.1097/JU.0000000000000495. Epub 2019 Aug 20.
- Impact of second transurethral resection on recurrence in patients with high-grade Ta bladder cancer
- Rikiya Taoka, Yuki Matsuoka, Kana Kohashiguchi, Takayoshi Miura, Yoichiro Tohi, Yasuyuki Miyauchi, Takuma Kato, Hiroyuki Tsunemori, Nobufumi Ueda, Yoshiyuki Kakehi, Mikio Sugimoto; Int J Urol. doi: 10.1111/iju.14372.
- Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab
- Takashi Kobayashi, Katsuhiro Ito, Takahiro Kojima, Minoru Kato, Souhei Kanda, Shingo Hatakeyama,
Yoshiyuki Matsui, Yuto Matsushita, Sei Naito, Masanobu Shiga, Makito Miyake, Yusuke Muro, Shotaro Nakanishi, Yoichiro Kato, Tadamasa Shibuya, Tetsutaro Hayashi, Hiroaki Yasumoto, Takashi Yoshida, Motohide Uemura, Rikiya Taoka, Manabu Kamiyama , Osamu Ogawa, Hiroshi Kitamura, Hiroyuki Nishiyama Japan Urological Oncology Group; Cancer Sci. doi: 10.1111/cas.14762.
- Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer
- Naoki Terada, Takashi Mizowaki, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Ken‐ichi Tabata, Masaki Shiota, Atsushi Takahashi, Toru Shimazui, Takayuki Goto, Yasuhiro Hashimoto, Masato Fujii, Ryotaro Tomida, Toshihiko Sakurai, Kohei Hashimoto, Sadafumi Kawamura, Shogo Teraoka, Shinichi Sakamoto, Takahiro Kimura. Manabu Kamiyama, Shintaro Narita, Nobumichi Tanaka, Takuma Kato, Masashi Kato, Takahiro Osawa, Takahiro Kojima, Takahiro Inoue, Mikio Sugimoto, Hiroyuki Nishiyama, Toshiyuki Kamoto; BJUI COMPASS, Volume1, Issue5 November 2020, Pages 165-173
- Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN.
- Hirama H, Sugimoto M, Miyatake N, Kato T, Venderbos LDF, Remmers S, Shiga K, Yokomizo A, Mitsuzuka K, Matsumoto R, Osawa T, Abe T, Sasaki H, Egawa S, Ninomiya I, Hashine K, Roobol MJ, Kakehi Y.; World J Urol. 2020 Oct 20. doi: 10.1007/s00345-020-03494-4.
- Quality of life in active surveillance for early prostate cancer
- Kato T, Sugimoto M; Int J Urol. 2020 Apr;27(4):296-306.
- Obstructive Sleep Apnea Syndrome as a Potential Cause of Nocturia in Younger Adults
- Yasuyuki Miyauchi, Homare Okazoe, Makiko Tamaki, Takako Kakehi, Hirohisa Ichikawa, Yukako Arakawa, Yoshihiro Mori, Fumikazu Koui, Mikio Sugimoto, Yoshiyuki Kakehi; Urology. 2020 Sep;143:42-47.
- Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma.
- Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Takeuchi A, Minami K, Nakai Y, Ueda K, Ozawa M, Uemura M, Miyauchi Y, Ohba K, Suzuki T, Anai S, Shindo T, Kusakabe N, Tamura K, Komiyama M, Goto T, Yokomizo A, Kohei N, Kashiwagi A, Murakami M, Sazuka T, Yasumoto H, Iwamoto H, Mitsuzuka K, Morooka D, Shimazui T, Yamamoto Y, Ikeshiro S, Nakagomi H, Morita K, Tomida R, Mochizuki T, Inoue T, Kitamura H, Yamada S, Ito YM, Murai S, Nishiyama H, Shinohara N; Japanese Urological Oncology Group.; Cancer Sci. 2020 Jul;111(7):2460-2471.
- The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2.
- Naito H, Kato T, Ishikawa R, Tanaka K, Ueda N, Matsuoka Y, Miyauchi Y, Taoka R, Tsunemori H, Haba R, Nishiyama Y, Sugimoto M, Kakehi Y.; Urology. 2020 Dec 5:S0090-4295(20)31431-X
- Absence of asymptomatic unruptured renal artery pseudoaneurysm on contrast-enhanced computed tomography after robot-assisted partial nephrectomy without parenchymal renorrhaphy
- Tohi Y, Murata S, Makita N, Suzuki I, Kubota M, Sugino Y, Inoue K, Ueda H, Kawakita M; Asian J Urol. 2020 Jan;7(1):24-28
- Surgical outcomes and learning curve of totally intracorporeal ileal conduit urinary diversion following laparoscopic radical cystectomy at a single institution
- Kubota M, Kokubun H, Yamaguchi R, Murata S, Makita N, Suzuki I, Suzuki R, Abe Y, Tohi Y, Tsutsumi N, Sugino Y, Inoue K, Kawakita M.; Asian J Endosc Surg. 2020 Oct;13(4):532-538
- Atypical oncologic failure after laparoscopic and robot-assisted radical cystectomy at a single institution.
- Kubota M, Kokubun H, Yamaguchi R, Murata S, Makita N, Suzuki I, Suzuki R, Abe Y, Tohi Y, Tsutsumi N, Sugino Y, Inoue K, Kawakita M.; Int J Clin Oncol. 2020 Jul;25(7):1385-1392
- The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.
-
Tohi Y, Kato T, Matsumoto R, Shinohara N, Shiga K, Yokomizo A, Nakamura M, Kume H, Mitsuzuka K, Sasaki H, Egawa S, Matsumura M, Hashine K, Inokuchi J, Eto M, Baba H, Ichikawa T, Kinoshita H, Matsuda T, Kakehi Y, Sugimoto M.; Int J Clin Oncol. 2020: 25, 2107-2114.
- Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy.
- Kubota M, Matsuoka T, Yamasaki T, Kokubun H, Hagimoto H, Murata S, Makita N, Suzuki I, Abe Y, Tohi Y, Tsutsumi N, Inoue K, Kawakita M.; Urology. 2020 Nov 25:S0090-4295(20)31407-2.
